HomeCompareTBGNF vs JEPQ

TBGNF vs JEPQ: Dividend Comparison 2026

TBGNF yields 1176.47% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TBGNF wins by $78814195.16M in total portfolio value
10 years
TBGNF
TBGNF
● Live price
1176.47%
Share price
$0.17
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78814195.20M
Annual income
$67,523,701,253,088.38
Full TBGNF calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — TBGNF vs JEPQ

📍 TBGNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTBGNFJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TBGNF + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TBGNF pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TBGNF
Annual income on $10K today (after 15% tax)
$100,000.00/yr
After 10yr DRIP, annual income (after tax)
$57,395,146,065,125.13/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, TBGNF beats the other by $57,395,146,063,295.42/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TBGNF + JEPQ for your $10,000?

TBGNF: 50%JEPQ: 50%
100% JEPQ50/50100% TBGNF
Portfolio after 10yr
$39407097.62M
Annual income
$33,761,850,627,620.48/yr
Blended yield
85.67%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TBGNF buys
0
JEPQ buys
0
No recent congressional trades found for TBGNF or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTBGNFJEPQ
Forward yield1176.47%11.10%
Annual dividend / share$2.00$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$78814195.20M$44.8K
Annual income after 10y$67,523,701,253,088.38$2,152.59
Total dividends collected$77969765.27M$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: TBGNF vs JEPQ ($10,000, DRIP)

YearTBGNF PortfolioTBGNF Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$128,347$117,647.06$11,930$1,110.39+$116.4KTBGNF
2$1,548,514$1,411,182.61$14,133$1,224.34+$1.53MTBGNF
3$17,569,052$15,912,142.01$16,632$1,340.46+$17.55MTBGNF
4$187,523,354$168,724,468.35$19,454$1,457.97+$187.50MTBGNF
5$1,883,716,681$1,683,066,692.55$22,626$1,576.08+$1883.69MTBGNF
6$17,816,329,317$15,800,752,468.33$26,175$1,694.09+$17816.30MTBGNF
7$158,731,384,105$139,667,911,735.60$30,133$1,811.32+$158731.35MTBGNF
8$1,332,782,916,056$1,162,940,335,063.89$34,531$1,927.17+$1332782.88MTBGNF
9$10,551,863,503,163$9,125,785,782,982.70$39,403$2,041.08+$10551863.46MTBGNF
10$78,814,195,201,473$67,523,701,253,088.38$44,787$2,152.59+$78814195.16MTBGNF

TBGNF vs JEPQ: Complete Analysis 2026

TBGNFStock

Oxurion NV, a biopharmaceutical company, develops and commercializes medicines for the treatment of eye diseases in Belgium and internationally. Its lead product is JETREA for the treatment of vitreomacular adhesion/vitreomacular traction. The company also develops THR-149, a plasma kallikrein inhibitor, which is in Phase II clinical trials for the treatment of diabetic macular edema (DME); and THR-687, an integrin antagonist which is in Phase II clinical trials for the treatment of DME. It has collaboration agreements with Bicycle Therapeutics, INC Research, and Galapagos NV. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.

Full TBGNF Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this TBGNF vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TBGNF vs SCHDTBGNF vs JEPITBGNF vs OTBGNF vs KOTBGNF vs MAINTBGNF vs XYLDTBGNF vs QYLDTBGNF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.